PyInvesting

Market research

KO2.F Korian

F EUR Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
1B
P/E ratio
132.73
Dividend yield
Not available
Beta
0.82

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 4 months ago

Korian is currently in a long term uptrend where the price is trading 5.6% above its 200 day moving average.

From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.8.

Korian's total revenue sank by 0.0% to $923M since the same quarter in the previous year.

Its net income has dropped by 0.0% to $32M since the same quarter in the previous year.

Finally, its free cash flow grew by 98.6% to $237M since the same quarter in the previous year.

Based on the above factors, Korian gets an overall score of 3/5.